by achcstg | Dec 28, 2022 | Clinical Labs
COVID-19 Tests Recalled and Others Approved; Cholera Review Urged Posted: December 28, 2022 COVID-19 tests continue to be frequent topics, as does cholera testing: The U.S. Food and Drug Administration (FDA) issued a bulletin about a COVID-19 test recall by...
by achcstg | Nov 2, 2022 | Clinical Labs
FDA and CDC Provide Updates for Monkeypox, COVID-19, and Ebola Testing Posted: November 2, 2022 Monkeypox Updates FDA Authorizes First Commercial Monkeypox Test Kit The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to Abbott...
by achcstg | Oct 4, 2022 | Clinical Labs
Specimen Collection, Shelf-Life Extensions, and More Posted: October 4, 2022 From best practices for collecting suspected monkeypox specimens to dealing with possible false negatives on COVID-19 testing, the CDC and the FDA provide updates and advice. Review the...
by achcstg | Sep 7, 2022 | ACH - Clinical Admin Topic, ACH - Facilities Topics, Acute Care Hospital, Ambulatory Surgery Center, CAH - Clinical Admin Topic, CAH - Facilities Topics, Clinical Labs, Critical Access Hospital, DMEPOS, Home Health, Hospice, Renal Dialysis
Preparing for the End of the COVID-19 PHE Posted: September 7, 2022 On January 30, 2023, the White House announced that the COVID-19 national emergency and public health emergency will end on May 11, 2023. As part of the emergency preparedness cycle, returning to...